[HTML][HTML] Tumor neoantigens: from basic research to clinical applications

T Jiang, T Shi, H Zhang, J Hu, Y Song, J Wei… - Journal of hematology & …, 2019 - Springer
Tumor neoantigen is the truly foreign protein and entirely absent from normal human organs/tissues.
It could be specifically recognized by neoantigen-specific T cell receptors (TCRs) in …

[HTML][HTML] Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma

G He, H Zhang, J Zhou, B Wang, Y Chen… - Journal of Experimental …, 2015 - Springer
Background PD-L1 expression on neutrophils contributes to the impaired immune response
in infectious disease, but the detailed role of PD-L1 expression on neutrophils in HCC …

[HTML][HTML] Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker

…, Y She, C Zhou, M Fang, Y Zhu, H Zhang… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Tumor mutational burden (TMB) is a significant predictor of immune checkpoint
inhibitors (ICIs) efficacy. This study investigated the correlation between deep learning …

[HTML][HTML] VEGF-D: a novel biomarker for detection of COVID-19 progression

Y Kong, J Han, X Wu, H Zeng, J Liu, H Zhang - Critical Care, 2020 - Springer
As the coronavirus 2019 (COVID-19) continues to spread globally, hundreds of thousands
have been infected, among whom approximately 15% of COVID-19 patients develop severe …

S100A4 promotes liver fibrosis via activation of hepatic stellate cells

L Chen, J Li, J Zhang, C Dai, X Liu, J Wang, Z Gao… - Journal of …, 2015 - Elsevier
Background & Aims S100A4 has been linked to the fibrosis of several organs due to its role
as a fibroblast-specific marker. However, the role of S100A4 itself in the development of …

Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms

F Li, Z Zheng, W Chen, D Li, H Zhang, Y Zhu… - Drug Resistance …, 2023 - Elsevier
Bladder cancer is one of the most common malignancies in the world. Cisplatin is one of the
most potent and widely used anticancer drugs and has been employed in several …

[HTML][HTML] Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell …

…, C Zhao, X Li, B Mao, W Zhu, X Guo, H Zhang… - Journal of hematology & …, 2019 - Springer
Introduction To depict the genomic landscape of Chinese early-stage lung squamous cell
carcinoma (LUSC) and investigate its correlation with tumor mutation burden (TMB), PD-L1 …

[HTML][HTML] Mutational spectrum and precision oncology for biliary tract carcinoma

…, J Long, Y Song, J Mao, F Xie, Y Bai, L Zhang… - Theranostics, 2021 - ncbi.nlm.nih.gov
Background: The genomic spectrum of biliary tract carcinoma (BTC) has been characterized
and is associated with distinct anatomic and etiologic subtypes, yet limited studies have …

[HTML][HTML] Enzymatic oxidation of tea catechins and its mechanism

B Abudureheman, X Yu, D Fang, H Zhang - Molecules, 2022 - mdpi.com
Tea (Camellia sinensis, Theaceae) is one of the most widely consumed beverages in the
world. The three major types of tea, green tea, oolong tea, and black tea, differ in terms of the …

[HTML][HTML] Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer

…, X Zhang, Z Peng, M Lu, Z Wang, H Zhang… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Despite the great achievements made in immune-checkpoint-blockade (ICB) in
cancer therapy, there are no effective predictive biomarkers in gastrointestinal (GI) cancer. …